Composition
- Active ingredients
- PROCHLORPERAZINE MALEATE EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PROCHLORPERAZINE MALEATE EQ 15MG BASE · Capsule, extended releaseNDA021019-002 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 10MG BASE · Capsule, extended releaseNDA021019-001 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 75MG BASE · Capsule, extended releaseNDA011000-004 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 15MG BASE · Capsule, extended releaseNDA011000-002 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 30MG BASE · Capsule, extended releaseNDA011000-003 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 10MG BASE · Capsule, extended releaseNDA011000-001 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010571-001 · Discontinued
- PROCHLORPERAZINE MALEATE EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- PROCHLORPERAZINE MALEATE EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010571-003 · Discontinued
At a glance
- Brand name
- Compazine
- Active substance
- prochlorperazine maleate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 23 Oct 1956
- Application
- NDA010571-002